# AP3B2

## Overview
The AP3B2 gene encodes the adaptor-related protein complex 3 subunit beta 2, a critical component of the adaptor protein complex 3 (AP-3). This complex is involved in the sorting and trafficking of proteins within cellular compartments, particularly in neuronal cells. The AP3B2 protein, also known as beta-NAP, is a part of a clathrin-independent heterotetrameric complex that plays a pivotal role in synaptic vesicle biogenesis and the proper targeting of synaptic vesicle membrane proteins, such as the zinc transporter ZnT3. This function is essential for maintaining synaptic zinc levels and ensuring the correct localization of proteins within neurons, which is crucial for normal synaptic function. Mutations in the AP3B2 gene have been linked to various neurological disorders, including early-onset epileptic encephalopathy and autoimmune conditions like paraneoplastic cerebellar ataxia, highlighting its significance in both neuronal and immune system processes (Mange2021Cerebellar; NewellLitwa2007Neuronal; Assoum2016AutosomalRecessive).

## Structure
The AP3B2 gene encodes a subunit of the adaptor protein complex 3 (AP-3), which is involved in protein sorting within cellular compartments such as the late-Golgi/trans-Golgi network and endosomes. The primary structure of the AP3B2 protein, also known as beta-NAP, consists of 1082 amino acids in its original form, AP3B2_v1. A novel splice variant, AP3B2_v2, has been identified, which is 145 amino acids long and lacks 22 exons present in AP3B2_v1, though both variants share the C-terminal 145 amino acids (Chen2007Characterization).

The AP3B2 protein is part of the AP-3 complex, which includes other subunits such as δ, μ3, and σ3. The complex adopts an open conformation, with the C-terminal domain of the μ3 subunit ejected from the 'bowl' formed by the large subunits (Begley2024A). The AP-3 complex is characterized by amphipathic helices in the δ and μ3 subunits, which are involved in membrane binding (Begley2024A). The AP-3 complex can form higher-order assemblies distinct from AP-1 due to differences in Arf1 binding and structural changes (Begley2024A). However, specific details on the secondary, tertiary, and quaternary structures of AP3B2 are not explicitly provided in the available context.

## Function
The AP3B2 gene encodes a subunit of the adaptor protein complex 3 (AP-3), which is crucial for the sorting and trafficking of synaptic vesicle membrane proteins in neuronal cells. This complex is involved in targeting proteins such as the zinc transporter ZnT3 to synaptic vesicles, ensuring their proper function and location within neurons (NewellLitwa2007Neuronal). AP-3 complexes containing the β3B subunit, which is specific to neurons, are essential for maintaining synaptic zinc levels and the correct targeting of synaptic vesicle proteins like ZnT3 and ClC-3 (Seong2005Genetic).

In the absence of AP3B2, there is a misrouting of ZnT3 to lysosomes instead of synaptic vesicles, leading to reduced zinc levels in synaptic vesicles and associated synaptic defects such as epilepsy and hyperactivity (NewellLitwa2007Neuronal). The AP-3 complex also plays a role in synaptic vesicle biogenesis from presynaptic endosomes, a process vital under high-frequency stimulation (NewellLitwa2007Neuronal). The presence of AP-3 in both axonal and dendritic processes suggests its involvement in both synaptic and extrasynaptic roles, highlighting its importance in maintaining proper neuronal function (Seong2005Genetic).

## Clinical Significance
Mutations in the AP3B2 gene are associated with several neurological disorders. Autosomal-recessive mutations in AP3B2 can lead to early-onset epileptic encephalopathy (EOEE), characterized by severe developmental delay, optic atrophy, and postnatal microcephaly (Assoum2016AutosomalRecessive). These mutations result in a neurological phenotype without symptoms related to immune or hematological functions (Mohammed2019Biallelic). 

AP3B2 is also implicated in autoimmune conditions. The presence of AP3B2 antibodies in serum or cerebrospinal fluid is linked to paraneoplastic cerebellar ataxia (PACA), a condition marked by subacute cerebellar ataxia, nystagmus, and cerebellar atrophy (Mange2021Cerebellar). Although the pathogenicity of these antibodies is not proven, they are considered specific markers for autoimmune cerebellar ataxia (Honorat2019Autoimmune). 

Additionally, AP3B2 has been identified as a potential biomarker for Lambert-Eaton Myasthenic Syndrome (LEMS), with studies suggesting its involvement in immune regulation and response pathways (Yang2021Identification). The gene's role in synaptic vesicle formation and its high expression in the nervous system underscore its importance in maintaining normal neurological function, and its dysregulation can lead to significant clinical manifestations.

## Interactions
The AP3B2 protein is a subunit of the adaptor protein complex 3 (AP-3), which is involved in vesicle trafficking. AP3B2 is part of a clathrin-independent heterotetrameric complex composed of beta, delta, mu, and sigma subunits. It interacts with other subunits like δ and 3 adaptins within the AP-3 complex, although these do not directly bind β3 but associate in the context of holotetramers (Zhuo2021AP3; Seong2005Genetic). 

AP3B2 has been shown to interact with the zinc transporter ZnT3, which is targeted to synaptic vesicles through an AP-3-dependent mechanism. This interaction is specific to the carboxy-terminal tail of ZnT3, indicating a direct role in synaptic vesicle targeting (Seong2005Genetic; Salazar2004The). 

In the context of autoimmune neurological disorders, AP3B2 interacts with IgG antibodies in patients with gait dysfunction due to ataxia. The IgG binds to a C-terminal polypeptide segment of AP3B2, suggesting a potential physiological presynaptic complex with N-type (Ca v 2.2) voltage-gated calcium channels (Honorat2019Autoimmune). 

AP3B2 also interacts with BLOC-1, a complex involved in the recognition and sorting of specific cargo proteins, such as SNAREs like VAMP7-TI, which is crucial for synaptic vesicle protein trafficking (NewellLitwa2007Neuronal).


## References


[1. (Zhuo2021AP3) Ma Zhuo, Islam Md. Nur, Xu Tao, and Song Eli. Ap-3 adaptor complex-mediated vesicle trafficking. Biophysics Reports, 7(2):91–100, 2021. URL: http://dx.doi.org/10.52601/bpr.2021.200051, doi:10.52601/bpr.2021.200051. This article has 2 citations.](https://doi.org/10.52601/bpr.2021.200051)

[2. (Seong2005Genetic) E. Seong, B. H. Wainer, E. D. Hughes, T. L. Saunders, M. Burmeister, and V. Faundez. Genetic analysis of the neuronal and ubiquitous ap-3 adaptor complexes reveals divergent functions in brain. Molecular Biology of the Cell, 16(1):128–140, January 2005. URL: http://dx.doi.org/10.1091/mbc.E04-10-0892, doi:10.1091/mbc.e04-10-0892. This article has 89 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E04-10-0892)

[3. (Salazar2004The) Gloria Salazar, Rachal Love, Erica Werner, Michele M. Doucette, Su Cheng, Allan Levey, and Victor Faundez. The zinc transporter znt3 interacts with ap-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation. Molecular Biology of the Cell, 15(2):575–587, February 2004. URL: http://dx.doi.org/10.1091/mbc.e03-06-0401, doi:10.1091/mbc.e03-06-0401. This article has 100 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e03-06-0401)

[4. (NewellLitwa2007Neuronal) Karen Newell-Litwa, Eunju Seong, Margit Burmeister, and Victor Faundez. Neuronal and non-neuronal functions of the ap-3 sorting machinery. Journal of Cell Science, 120(4):531–541, February 2007. URL: http://dx.doi.org/10.1242/jcs.03365, doi:10.1242/jcs.03365. This article has 109 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.03365)

[5. (Honorat2019Autoimmune) Josephe A. Honorat, A. Sebastian Lopez-Chiriboga, Thomas J. Kryzer, Lars Komorowski, Madeleine Scharf, Shannon R. Hinson, Vanda A. Lennon, Sean J. Pittock, Christopher J. Klein, and Andrew McKeon. Autoimmune gait disturbance accompanying adaptor protein-3b2-igg. Neurology, September 2019. URL: http://dx.doi.org/10.1212/wnl.0000000000008061, doi:10.1212/wnl.0000000000008061. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0000000000008061)

[6. (Mange2021Cerebellar) Liu Mange, Ren Haitao, Zhou Lixin, Fan Siyuan, Wang Jing, and Guan Hongzhi. Cerebellar ataxia and myeloradiculopathy associated with ap3b2 antibody: a case report and literature review. Journal of Neurology, 268(11):4163–4169, May 2021. URL: http://dx.doi.org/10.1007/s00415-021-10496-8, doi:10.1007/s00415-021-10496-8. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00415-021-10496-8)

[7. (Chen2007Characterization) Chunjing Chen, Chunjing Chen, Xianqiong Zou, Chunjing Chen, Xianqiong Zou, Chaoneng Ji, Shuo Zhao, Lei Lv, Shaohua Gu, Yi Xie, Chunjing Chen, Xianqiong Zou, Chaoneng Ji, Shuo Zhao, Lei Lv, Shaohua Gu, Yi Xie, and Yumin Mao. Characterization ofap3b2_v2, a novel splice variant of humanap3b2: short communication. DNA Sequence, 18(3):165–168, January 2007. URL: http://dx.doi.org/10.1080/10425170600842121, doi:10.1080/10425170600842121. This article has 1 citations.](https://doi.org/10.1080/10425170600842121)

[8. (Mohammed2019Biallelic) Mohammed Mohammed, Nadia Al-Hashmi, Samiya Al-Rashdi, Nashat Al-Sukaiti, Kawther Al-Adawi, Marwa Al-Riyami, and Almundher Al-Maawali. Biallelic mutations in ap3d1 cause hermansky-pudlak syndrome type 10 associated with immunodeficiency and seizure disorder. European Journal of Medical Genetics, 62(11):103583, November 2019. URL: http://dx.doi.org/10.1016/j.ejmg.2018.11.017, doi:10.1016/j.ejmg.2018.11.017. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2018.11.017)

9. (Yang2021Identification) Identification of LOC338963 and AP3B2 as Potential Biomarkers for Lambert-Eaton Myasthenic Syndrome. This article has 0 citations.

[10. (Assoum2016AutosomalRecessive) Mirna Assoum, Christophe Philippe, Bertrand Isidor, Laurence Perrin, Periklis Makrythanasis, Neal Sondheimer, Caroline Paris, Jessica Douglas, Gaetan Lesca, Stylianos Antonarakis, Hanan Hamamy, Thibaud Jouan, Yannis Duffourd, Stéphane Auvin, Aline Saunier, Amber Begtrup, Catherine Nowak, Nicolas Chatron, Dorothée Ville, Kamiar Mireskandari, Paolo Milani, Philippe Jonveaux, Guylène Lemeur, Mathieu Milh, Masano Amamoto, Mitsuhiro Kato, Mitsuko Nakashima, Noriko Miyake, Naomichi Matsumoto, Amira Masri, Christel Thauvin-Robinet, Jean-Baptiste Rivière, Laurence Faivre, and Julien Thevenon. Autosomal-recessive mutations in ap3b2, adaptor-related protein complex 3 beta 2 subunit, cause an early-onset epileptic encephalopathy with optic atrophy. The American Journal of Human Genetics, 99(6):1368–1376, December 2016. URL: http://dx.doi.org/10.1016/j.ajhg.2016.10.009, doi:10.1016/j.ajhg.2016.10.009. This article has 48 citations.](https://doi.org/10.1016/j.ajhg.2016.10.009)

11. (Begley2024A) A structure-based mechanism for initiation of AP-3 coated vesicle formation. This article has 0 citations.